Liabilities / Assets
21st percentile
Higher debt load relative to assets than 21% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
21st percentile
Higher debt load relative to assets than 21% of similar nonprofits.
Liabilities / Revenue
33rd percentile
Higher debt load relative to revenue than 33% of similar nonprofits.
Net Margin
27th percentile
Higher net margin than 27% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
60th percentile
Faster asset growth than 60% of similar nonprofits.
Revenue Growth
23rd percentile
Faster revenue growth than 23% of similar nonprofits.
Assets
Up$14,839,446
Up $659,849 (+4.7%) from 2011
Net Assets
Up$14,272,053
Up $688,488 (+5.1%) from 2011
Liabilities
Down$567,393
Down $28,639 (-4.8%) from 2011
Revenue
Down$5,010,644
Down $598,166 (-11%) from 2011
Expenses
Up$5,164,621
Up $217,393 (+4.4%) from 2011
Net Income
Down-$153,977
Down $815,559 (-123%) from 2011
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To advance medical and scientific research through the transfer of technology from the laboratory to public use by obtaining patents and licenses and administering patents arising out of discoveries made pursuant to research conducted or sponsored by Clayton Foundation for Research and its supporting organizations.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.